China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
China NT Pharma Group Co., Ltd. has reported a turnaround with a net profit of 661 thousand RMB for the six months ending June 30, 2024, bouncing back from a loss of 5.6 million RMB in the same period the previous year. This positive shift in financials is due to a significant decrease in finance costs and general expenses, coupled with a steady share of results from associates. The company’s gross profit also saw a slight dip but remained in the green with 5.7 million RMB.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.
